Kosuke Okasho
Hirakata, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Establishment and Characterization of Patient-Derived Xenograft Organoids for Personalized Treatment of Castration-Resistant Prostate Cancer.
Journal: The Prostate
Published: December 14, 2025
Incidence, risk factors, and clinical implications of enfortumab vedotin-related cutaneous toxicity in urothelial carcinoma: a large-scale, real-world study in Japan.
Journal: ESMO real world data and digital oncology
Published: December 16, 2024
A highly sensitive screening system to evaluate the reversibility of neuroendocrine prostate cancer to prostate adenocarcinoma.
Journal: Cancer medicine
Published: March 22, 2024
Up-regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapy.
Journal: Cancer medicine
Published: April 30, 2022
Identification of the α2 chain of interleukin-13 receptor as a potential biomarker for predicting castration resistance of prostate cancer using patient-derived xenograft models.
Journal: Cancer reports (Hoboken, N.J.)
Published: January 28, 2022
Narrative review of challenges in the management of advanced neuroendocrine prostate cancer.
Journal: Translational andrology and urology
Published: July 29, 2020
Consecutive Prostate Cancer Specimens Revealed Increased Aldo⁻Keto Reductase Family 1 Member C3 Expression with Progression to Castration-Resistant Prostate Cancer.
Journal: Journal of clinical medicine
Published: March 27, 2019
Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer.
Journal: Scientific reports
Published: September 09, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026